$7.99
0.243.03%
At close: Jul 15, 5:00 PM EST
$7.80
-0.19-2.38%
After Hours: 6:15 PM EST
Sagimet Biosciences Inc Earnings Estimates
SGMTNASDAQ
Sagimet Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:SGMT
Sagimet Biosciences (SGMT) is scheduled to report Q2 earnings on August 12, 2026. Analysts estimate EPS of $-0.27 and quarterly revenue of N/A.
In the most recent quarter (Q1), Sagimet Biosciences reported EPS of $-0.33, beating estimates of $-0.36 by 0.08%. Revenue came in at $0, meeting the estimate of $0 by 0.00%.
Sagimet Biosciences has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Sagimet Biosciences has averaged an EPS surprise of 0.19% and a revenue surprise of 1.00%.
Earnings Date
Aug 12
EPS Estimate
$-0.270
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Sagimet Biosciences Earnings History
Analyze the earnings history of Sagimet Biosciences using advanced sorting and filters.
Loading calendar...
Sagimet Biosciences (SGMT) Earnings Per Share
The chart below shows Sagimet Biosciences's reported EPS compared to analyst estimates over recent quarters.
Sagimet Biosciences (SGMT) Revenue
The chart below shows Sagimet Biosciences's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Sagimet Biosciences (NASDAQ:SGMT) reporting earnings?
Sagimet Biosciences (SGMT) is scheduled to report earnings on August 12, 2026. The last reported earnings were for reported on May 12, 2026 for Q1.
What were the latest earnings per share (EPS) for Sagimet Biosciences (NASDAQ:SGMT)?
The Actual EPS was $-0.33, which beat the estimate of $-0.36.
What were Sagimet Biosciences’s (NASDAQ:SGMT) revenues?
The Actual Revenue was $0, which hit the estimate of $0.
